Click here for slides on this topic


Insulin detemir

A long-acting insulin for glycemic control in diabetes.
The following content matched the glossary term: Insulin detemir

CompanionSetType2DiabetesMedications

Top

Patient education companion set featuring handouts on DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and medications used to treat type 2 diabetes (English and Spanish)

Medications Used To Treat Type 2 Diabetes

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose.

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

Medicamentos para el tratamiento de la diabetes tipo 2

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose—in Spanish.

ADA 2016 Type 1 Diabetes Pharmacologic Therapy

Top

Type 1 diabetes treatment options from the 2016 ADA guidelines

ADA 2016 Insulin & Glucose Monitoring

Top

Recommendations for insulin and glucose monitoring in diabetes (SMBG) from the 2016 ADA guidelines

ADA 2016 Type 2 Diabetes Pharmacologic Therapy

Top

Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

Clinical Insights April 2013

Top

The latest diabetes literature exploring diabetes guidelines, diabetes treatment, diabetes management, and diabetes prevention with commentary from diabetes experts.

Once-weekly exenatide vs once- or twice-daily insulin detemir: efficacy and safety in patients with type 2 diabetes

Top

Davies M, Heller S, Sreenan S, et al. Once weekly exenatide versus once or twice daily insulin detemir randomized, open label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas. Diabetes Care. 2013;36(5):1368-1376. Type 2 diabetes is often linked to obesity and requires multiple interventions to achieve A1C goals. Thus, treatments that improve glycemia and body weight with low hypoglycemia risk may be more beneficial than treatments that cause weight gain.

1 2 Next 

Slide Library Results

Search Results for: Insulin detemir Slides Found: 9
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: Background
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: Design
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: Primary Endpoint
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: Mean A1C Change
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: A1C Target at Endpoint
Once-Weekly Exenatide Vs Once- or Twice-Daily Insulin Detemir: Mean Body Weight Change
Diabetes Pregnancy Guidelines Insulin Therapy | NDEI
Diabetes Pregnancy Guidelines Preconception Insulin | NDEI
Basal Insulin Glycemic Control A1C Type 2 Diabetes | NDEI